Innovative mobile app for quantification and estimation of tremor (QuEsT)
| Reference number | |
| Coordinator | STARDOTS AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | March 2019 - March 2020 |
| Status | Completed |
| Venture | Innovative Startups |
| Call | Innovative Startups step 1 spring 2019 |
Important results from the project
The aim of the project was to develop a mobile application (Tremoor) that can quantify the amount of tremor, i.e., involuntary shaking, a person has. We acquire sensor data via the Tremoor-application and send it to our cloud server for calculations and mathematical modeling. We have performed clinical trials on both healthy and people with different degrees of tremor and different treatments. The market and the economic conditions for symptom quantification of tremor have been verified with the help of various actors including caregivers and patients themselves.
Expected long term effects
The application and the state-of-the-art algorithms and mathematical modeling prove to be an extremely powerful, objective and robust way of determining how many shakes a patient has. The clinical trials show that it is easy to determine how much tremor a person has, the effect of any treatment and the progression of the disease in general. Stardots will seek regulatory approval for the application and launch it for clinics within the EU and the US in the coming years. Stardots will embed the application and modeling of the symptoms in our digital health platform for Parkinson´s disease.
Approach and implementation
Stardots developed the application in a cross-platform framework for faster iOS and Android versions. The algorithms were thoroughly tested on-premise in order to optimize these for the cloud. The clinical trials were performed at the Academic Hospital in Uppsala. We work closely with Boston´s vibrant life science community for contacts and help with perhaps the world´s best in digital health and MedTech products. The project was carried out with help from Uppsala University, Uppsala University Hospital and Acaya AB.